Open an account

T2 Biosystems

TTOO · OTC

$0.0008+$0.0001 (+14.29%)TodayMarket closed ·
Prev close $0.0007

About TTOO

T2 Biosystems, Inc. is a vitro diagnostics company, which engages in the development of detection of sepsis-causing pathogens. The company is headquartered in Lexington, Massachusetts and currently employs 113 full-time employees. The company went IPO on 2014-08-07. Its technology enables detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets at limits of detection as low as one colony forming unit per milliliter (CFU/mL). Its focus includes three areas: sepsis, bioterrorism, and Lyme disease. The firm's products include the T2Dx Instrument, the T2Bacteria Panel, the T2Candida Panel, the T2Resistance Panel, and the T2Biothreat Panel, and are powered by the T2 Magnetic Resonance (T2MR) technology. The company also has an active pipeline of products, including the United States T2Resistance Panel, the Candida auris test, and the T2Lyme Panel. T2Dx Instrument is a fully automated instrument that is capable of running a range of diagnostic tests from patient samples.

Employees
113
Headquarters
Lexington, Massachusetts
Listed
Aug 7, 2014
Sector
Health Care
Industry
Biotechnology
Website
t2biosystems.com

TTOO key statistics

Market cap
22.44K
Price-earnings ratio
0.00
Dividend yield
—
Average volume
4.61K
Volume
28.14K
Open price
$0.0008
High today
$0.0008
Low today
$0.0008
52 Week high
$0.05
52 Week low
$0.0001

T2 Biosystems (TTOO) at a glance

As of Oct 20, 2026, T2 Biosystems (TTOO) shares are priced at $0.0008, giving the company a market cap of 22.44K and a price-to-earnings ratio of 0.00.

Volume so far is 28.14K shares, above the average of 4.61K shares a day.

Over the past year T2 Biosystems has ranged from $0.0001 to $0.05, and now sits 1% of the way up that range.

T2 Biosystems met or beat analyst EPS estimates in 4 of the last 8 quarters. In Q2 FY24 it reported -$0.66 per share against an estimate of -$0.9894.

TTOO earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 4 of the last 8 quarters, by 33.7% on average.

  1. Q2 FY22: reported -$500.00 per share against an estimate of -$459.00
  2. Q3 FY22: reported -$295.00 per share against an estimate of -$208.42
  3. Q4 FY22: reported -$141.00 per share against an estimate of -$173.91
  4. Q1 FY23: reported -$132.00 per share against an estimate of -$122.74
  5. Q2 FY23: reported -$8.00 per share against an estimate of -$27.20
  6. Q3 FY23: reported -$3.45 per share against an estimate of -$3.93
  7. Q1 FY24: reported -$2.66 per share against an estimate of -$1.90
  8. Q2 FY24: reported -$0.66 per share against an estimate of -$0.9894

TTOO news

  • Insights Ahead: T2 Biosystems's Quarterly Earnings

Similar companies

Companies in the same industry as T2 Biosystems

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.